ArticleBrain and behavior2025
Antibody Responses to EBV and Toxoplasma and Their Genetic Links to Guillain-Barré Syndrome: A Mendelian Randomization Study.
Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aims to investigate the potential causal relationship between antibody-mediated immune responses to infectious agents and Guillain-Barré syndrome (GBS) using a two-sample Mendelian randomization (MR) approach.
methodsPublicly available summary data from genome-wide association studies (GWAS) were utilized for comprehensive analysis. A genome-wide and human leukocyte antigen association study conducted by Guillaume Butler-Laporte et al. (n = 9724) examined 46 types of antibody-mediated immune responses. GWAS summary statistics for GBS were obtained from the FinnGen consortium (n = 215,931) comprising European populations. The primary method for MR analysis was the inverse-variance weighted (IVW) method. Various sensitivity analyses were conducted to assess the heterogeneity and pleiotropy of the findings.
resultsThe IVW method indicates a negative correlation between elevated levels of Epstein-Barr virus (EBV) viral capsid antigen (VCA) p18 antibody and the risk of GBS (OR = 0.79, 95% confidence interval [CI]: 0.65-1.85, p = 0.012). Elevated levels of Toxoplasma gondii surface antigen 1 (sag1) antibody also show a negative correlation with the risk of GBS (OR = 0.79, 95% CI: 0.67-0.92, p = 0.003). No evidence of heterogeneity or horizontal pleiotropy was found in the MR analysis.
conclusionsElevated levels of EBV VCA p18 and T. gondii sag1 antibodies appear to be negatively correlated with the risk of GBS, suggesting that immune responses to these pathogens may play a protective role. However, the CI for the EBV VCA p18 association includes 1, indicating the need for caution in interpreting this result. Further research, including mechanistic studies and broader immune profiling, is needed to confirm these findings and explore the underlying pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.